References
- CTCAE v4.03; 6 14, 2020 Available from: https://www.eortc.be/services/doc/ctc/ctcae_4.03_2010-06-14_quickreference_5x7.pdf. Accessed 910, 2019.
- CTCAE v5.0; 11 27, 2017 Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed 910, 2019.
- BrottDA, GoodmanMJ, HermannRP, et al. Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations? Drug Des Devel Ther. 2018;12:2757–2773. doi:10.2147/DDDT.S173671
- SteinbergW, NauckMA, ZinmanB, et al.; LEADER Trial investigators. LEADER 3-Lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER trial. Pancreas. 2013;166(5):823–830.
- BalkecemiL, BelaliaM. Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: Wilaya of Mostaganem. Diabetes Metab Syndr. 2016;10(Suppl 1):S147–S150. doi:10.1016/j.dsx.2015.10.01326711007
- RashidMH, HaqueMZ, RahmanMK, et al. Study on liver dysfunction in type 2 diabetic patients in Bangladesh. Euroasian J Hepatogastroenterol. 2016;6(1):1–4. doi:10.5005/jp-journals-10018-115529201714
- SalmelaPI, SotaniemiEA, NiemiM, MäentaustaO. Liver function tests in diabetic patients. Diabetes Care. 1984;7(3):248–254. doi:10.2337/diacare.7.3.2486734394
- BhuyanP, ChenC, DesaiJ, et al. Development and Implementation of a pharma-collaborative large historical control database; 2017 Available from: http://www.transceleratebiopharmainc.com/wp-content/uploads/2015/04/TransCelerate-PSoC-Data-Sharing-White-Paper.pdf. Accessed 330, 2017.
- Reference intervals for clinical and lab medicine. Available from: https://ncss-wpengine.netdna-ssl.com/wp-content/themes/ncss/pdf/Procedures/PASS/Reference_Intervals_for_Clinical_and_Lab_Medicine.pdf. Accessed 521, 2020.
- MorseEE, KalacheG, GerminoW, StockwellR. Increased electronic mean corpuscular volume induced by marked hyperglycemia. Ann Clin Lab Sci. 1981;11(2):184–187.7259094
- AlamriBN, BahabriA, AldereihimA, et al. Hyperglycemia effect on red blood cells indices. Rev Med Pharmacol Sci. 2019;23(5):2139–2150.
- FurukawaS, SakaiT, NiiyaT, et al. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: the Dogo study. Endocr J. 2017;64(12):1131–1136. doi:10.1507/endocrj.EJ17-025628855437
- WanX, ZhangL, GuH, WangS, LiuX. The association of serum hsCRP and urinary alpha-1 microglobulin in patients with type 2 diabetes mellitus. Biomed Res Int. 2019;2019:1–10. doi:10.1155/2019/6364390